ARTICLE | Clinical News
Probuphine buprenorphine: Completed Phase III enrollment
December 8, 2014 8:00 AM UTC
Titan said partner Braeburn Pharmaceuticals S.p.r.l. (Princeton, N.J.) completed enrollment of 178 clinically stable patients in a double-blind, placebo-controlled Phase III trial evaluating 4 Probup...